Obermatt
See Similar Stocks →

CVS Health

NYQ:CVS · US1266501006
Health Care Providers & ServicesXX-Large

360

29
EV / EBIT67
Price / Owner Earnings23
Owner Earnings Yield50
Dividend Yield99
Price/Sales83
EV / Gross Profit75
Price/Book66
Return on Capital48
Cash Return on Capital49
Return on Equity43
EBIT Margin35
Gross Profitability35
Cash Conversion76
Accruals38
Owner Earnings Margin39
Sales growth18
Profit Growth98
Long-Term EPS Growth46
Owner Earnings Growth16
Reinvestment67
Price momentum85
Debt load44
Refinancing7
Debt Payback13
Liquidity60
Analyst ratings68
Opinion Changes49
Price Target Upside24
Market mood27
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

CVS Health clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Providers & Services
SizeXX-Large
TypePublic Company
ExchangeNYSE
Founded1996
Employees69,794
Websitecvshealth.com
ISINUS1266501006
Last UpdateApr 2, 2026
Indices
S&P 500 (USA)D.J. US Health Care
Themes
Process AutomationCorporate Wellness ProgramsChronic DiseasesHealth DiagnosticsArtificial IntelligenceDigital WellnessEmployee Assistance Program (EAP)Employee BenefitsHealth CareMedicalPharmaceuticalRetailSales

Description

CVS Health Corporation (‘CVS Health’), together with its subsidiaries, operates as a health solutions company. As of December 31, 2025, the company had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics, a…

Analysis

Middle-of-the-road

CVS Health Corporation is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 28.0× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 11% yearly growth; analysts expect 12%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is stretched. The company scores 12/20 on our value-creation score: creating some value.

What to watch: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
89
2023202420252026

All-time high

95

Nov 2025

All-time low

41

Jan 2024

Average rank

75

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
83
85
82
79
Price/Earnings
70
78
94
77
Price/Book
66
74
80
90
Dividend Yield
99
98
96
100
Value (overall)
99
100
98
100

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare CVS Health with its peers
Elevance Health
NYQ:ELV
47
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Progyny
NSQ:PGNY
92
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
National Research
NSQ:NRC
43
CountryUSA
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Hims & Hers Health
NYQ:HIMS
3
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
InnovAge
NSQ:INNV
35
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Brightspring Health Services
NSQ:BTSG
86
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →